Aslan Fred sold ARTV

May 19, 2026 · Form 4 insider transaction

Aslan Fred sold 27,116 shares of Artiva Biotherapeutics, Inc. at $9.01 per share, a transaction worth $244.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
27,116
Price
$9.01
Total value
$244.3K
InsiderAslan Fred
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 19, 2026
Filing dateMay 19, 2026
Shares owned after1,535,082
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and release of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.; The weighted average sale price for the transaction reported was $9.0077, and the range of prices were between $8.7383 and $9.0104. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

View the original Form 4 on SEC EDGAR